Last 715.05 INR
Change Today +14.05 / 2.00%
Volume 73.7K
PIEL On Other Exchanges
Symbol
Exchange
Natl India
As of 1:22 AM 08/20/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Peter De Young

AgeTotal Calculated CompensationThis person is connected to 4 board members in 1 different organizations across 2 different industries.

See Board Relationships
----

Background*

Mr. Peter De Young serves as a Director of Ascendancy Healthcare, Inc. Mr. De Young is jointly responsible for the NCE Research division of Piramal Enterprises, Piramal Life Sciences. His specific responsibilities in the NCE Research division include business development, strategy, finance, project management and development. He is also on the board of Piramal Imaging.SA. Prior to joining Piramal, he has worked in a range of investing and consulting roles in healthcare ...

Read Full Background

Corporate Headquarters*

Piramal Tower
Mumbai, Maharashtra 400013

India

Phone: 91 22 3046 6666
Fax: 91 22 3046 7855

Board Members Memberships*

Director
2012-N/A
Former Director

Education*

MBA
The Leland Stanford Junior University
BS
Princeton University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PIEL:IN 715.05 INR +14.05

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Samir Uttamlal Mehta M.B.A.Executive Vice Chairman, Managing Director, Member of Securities Transfer & Stakeholders Relationship Committee and Member of Committee of Directors
Torrent Pharmaceuticals Ltd.
313.0K
Shailesh Ayyangar B.V.Fc & A.H., P.G.D.M.Managing Director, Vice President of South Asia - Global Operations, Executive Director and Member of Audit Committee
Sanofi India Limited
8.6M
Murali Krishna Prasad Divi M. Pharm, Ph.D.Chairman, Managing Direector and Member of Corporate Social Responsibility Committee
Divi's Laboratories Limited
9.0M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PIRAMAL ENTERPRISES LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.